CastleKeep Investment Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,411
Closed -$1.73M 73
2025
Q4
$1.73M Hold
39,411
0.78% 35
2025
Q3
$1.63M Buy
39,411
+7,919
+25% +$318K 0.76% 38
2025
Q2
$1.39M Buy
+31,492
New +$1.26M 0.68% 35

Other funds holding EXEL

CastleKeep Investment Advisors's EXEL Position: Q1 2026 in Review

CastleKeep Investment Advisors sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 39,411 shares — an estimated $1.73M sold.

CastleKeep Investment Advisors first reported a position in EXEL in Q2 2025 and held it in 3 quarters. The position peaked at $1.73M in Q4 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • CastleKeep Investment Advisors reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • CastleKeep Investment Advisors sold 39,411 Exelixis shares in Q1 2026, an estimated $1.73M.
  • CastleKeep Investment Advisors first reported a position in Exelixis in Q2 2025 and held it in 3 quarters.
  • CastleKeep Investment Advisors's Exelixis position peaked at $1.73M in Q4 2025.
  • 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on CastleKeep Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.